Martine Gilard1, MD; Michael Schlüter2, PhD; Thomas M. Snow3, MD; Gianni Dall’Ara4, MD; Helene Eltchaninoff5, MD; Neil Moat4, MS, FRCS; Javier Goicolea6, MD; Gian Paolo Ussia7, MD; Petr Kala8, MD, PhD; Peter Wenaweser9, MD; Marian Zembala10, MD, PhD; Georg Nickenig11, MD, PhD; Susanna Price4, MD; Eduardo Alegria Barrero12, MD; Bernard Iung13, MD; Pepe Zamorano14, MD; Gerhard Schuler15, MD; Roberto Corti16, MD; Ottavio Alfieri17
1. Centre Hospitalier Universitaire (CHU) Brest, Brest, France; 2. Asklepios Proresearch, Hamburg, Germany; 3. King’s College Hospital, London, United Kingdom; 4. NIHR Cardiovascular BRU Royal Brompton Hospital, London, United Kingdom; 5. University Hospi
Aims: Our aim was to assess one-year outcomes of patients enrolled in the pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation (TAVI).
